Pediatric Growth Hormone Deficiency Clinical Trials

Find Pediatric Growth Hormone Deficiency Clinical Trials Near You

BELux Children OutcoME During A(@)Dulthood With Growth Hormone Deficiency

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Our objective is to evaluate the outcome in adulthood of Belgian and Luxembourgish patients treated with rhGH during childhood for CO-GHD. The primary goal is to determine the proportion of adult CO-GHD patients who continue to receive regular medical follow-up and those still undergoing rhGH therapy using a questionnaire. Secondary objectives include assessing the regularity of follow-up and compliance with treatment in adulthood, evaluating possible comorbidities, health issues, lifestyle, living environment, and quality of life. Additionally, we aim to assess the metabolic profile in adulthood, particularly focusing on BMI, glycemic, and lipid data, for patients who consent to share their current clinical and biological data. Data will be described according to treatment adherence and CO-GHD etiology/phenotypes (e.g., idiopathic vs. organic GHD, isolated vs. combined GHD, partial vs. severe GHD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> or = 18 years

• Diagnosed with child-hood onset growth hormone deficiency (CO-GHD) (no exclusion criteria: isolated or multiple GHD, idiopathic or organic, severe or partial)

• Registered in the BELGROW registry (informed consent at the time of inclusion in registry)

• Stopped treatment with rhGH for growth after 2011

• Persistent GHD at the end of growth

Locations
Other Locations
Belgium
Cliniques Universitaires Saint-Luc
RECRUITING
Brussels
Contact Information
Primary
Philippe Lysy, MD, PhD
philippe.lysy@saintluc.uclouvain.be
02 7641370
Backup
Laure Boutsen, MD
laure.boutsen@saintluc.uclouvain.be
02 7641933
Time Frame
Start Date: 2025-05-21
Estimated Completion Date: 2029-05-01
Participants
Target number of participants: 200
Treatments
No_intervention: Patients with regular follow-up for their GHD (treated with rhGH or not)
Patients with regular follow-up for their GHD (treated with rhGH or not) in a adult endocrinology department including a clinical examination and endocrine blood work-up at least once a year
Active_comparator: Patients who are lost to follow-up or not regularly followed for their GHD
Patients who are lost to follow-up or not regularly followed for their GHD (or only followed by their GP with no endocrine assessment)
Sponsors
Leads: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

This content was sourced from clinicaltrials.gov